Review
Transdermal estradiol. A potentially improved method of hormone replacement
Affiliations
- PMID: 8064701
Item in Clipboard
Review
Transdermal estradiol. A potentially improved method of hormone replacement
J Reprod Med.
1994 May.
Abstract
Estrogen replacement is usually administered as an oral preparation. Concerns have been expressed about the impact these oral preparations have on hepatic function. This paper reviews studies of one nonoral preparation that delivers estradiol into the systemic circulation by use of a transdermal system. Support for this delivery system for treating menopausal symptoms and, potentially, for avoiding side effects is presented.
Similar articles
-
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.Thromb Haemost. 2001 Apr;85(4):619-25. Thromb Haemost. 2001. PMID: 11341495 Clinical Trial.
-
Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.Int J Fertil Womens Med. 1997;42 Suppl 2:376-87. Int J Fertil Womens Med. 1997. PMID: 9397385 Clinical Trial.
-
A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.Eur J Obstet Gynecol Reprod Biol. 2007 Feb;130(2):206-11. doi: 10.1016/j.ejogrb.2006.05.021. Epub 2006 Jun 30. Eur J Obstet Gynecol Reprod Biol. 2007. PMID: 16814449 Clinical Trial.
-
[Hormone replacement therapy - less is often more].Zentralbl Gynakol. 2001 Sep;123(9):546-7. doi: 10.1055/s-2001-18230. Zentralbl Gynakol. 2001. PMID: 11709750 Review. German.
-
Transdermal estrogen and prevention of osteoporosis.Am Fam Physician. 1994 May 15;49(7):1639-44. Am Fam Physician. 1994. PMID: 8184798 Review.
Cited by
-
Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System.Clin Drug Investig. 1995 Sep;10(3):172-8. doi: 10.2165/00044011-199510030-00006. Clin Drug Investig. 1995. PMID: 27519201